Skip to content
Peptigraph home

AOD-9604 Dosage: Doses Studied, Units and Chart

What doses of AOD-9604 have been used in published research, how they convert to syringe units, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureHGH fragment analogUpdated
Doses studied
2 studies
with a stated dose, listed below
Frequency
Varies by study
as used in studies
Half-life
Not found
No published half-life found (PubMed search, 11 Oct 2026)
Vial sizes sold
2 mg, 5 mg, 10 mg

Doses used in published studies

Each dose below is quoted from a study abstract, strongest design first. Animal doses are labelled and do not translate directly to people. None of them is a recommendation.

Doses of AOD-9604 used in published studies
DoseFrequency and routeStudy typeSource
0.25 mg AOD9604 +/- 6 mg hyaluronic acidweekly · intra-articular · 4-7 weeks after the first collagenase injectionAnimal · rabbit (not a human result)n = 32Annals of clinical and laboratory science 2015, PMID 26275694
500 microg/kg body weightdaily · oral · 19 daysAnimal · rat (not a human result)Hormone research 2000, PMID 11146367

Dose to syringe units

For a 10 mg vial mixed with 2 mL of bacteriostatic water (5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.

100 mcg
2 u
250 mcg
5 u
300 mcg
6 u
500 mcg
10 u
750 mcg
15 u
1000 mcg
20 u
Use your own vial and water

Before anyone considers it

  • AOD-9604 is not FDA approved for any use.
  • Products sold as research chemicals are not checked by the FDA for identity, purity or dose.
  • Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
  • People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.

The only amounts on record are from rats and rabbits, by different routes

In obese Zucker rats, a daily oral dose of 500 microg/kg body weight for 19 days reduced weight gain by over 50% versus controls.[4]

In a rabbit knee model, 0.25 mg was injected into the joint weekly, alone or with 6 mg hyaluronic acid, for 4-7 weeks after collagenase injury.[3]

Drugs@FDA lists no AOD-9604 product, so no labelled human dose exists to compare these animal figures against.[7]

Common questions

How many units is 300 mcg of AOD-9604?

It depends on the water added. A 10 mg vial with 2 mL of water gives 5 mg/mL, so 300 mcg is 6 units on a U-100 syringe. Use the calculator for other mixes.

Is AOD-9604 FDA approved?

No. AOD-9604 is not FDA approved for any use.

What is the AOD-9604 dosage chart?

Drugs@FDA lists no AOD-9604 product, and the amounts cited here come from animal studies.[7]

Is there an AOD-9604 protocol?

The one injected protocol on record is a rabbit joint study with weekly 0.25 mg injections for 4-7 weeks, which is animal evidence.[3]

More on AOD-9604

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.Annals of clinical and laboratory science · 2015PMID 26275694Accessed 2 Oct 2026
  4. 4Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.Hormone research · 2000PMID 11146367Accessed 2 Oct 2026
  5. 5PubMed search: AOD9604[tiab] OR "AOD-9604"[tiab] OR "AOD 9604"[tiab] (22 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: (AOD9604[tiab] OR "AOD-9604"[tiab] OR "AOD 9604"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  7. 7Drugs@FDA (openFDA) search: active ingredient "AOD-9604"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026

Found an error? Report a correction.